Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

CF Patients' COVID antibodies tracked in new study

NCT ID NCT05054582

First seen Feb 02, 2026 · Last updated May 23, 2026 · Updated 10 times

Summary

This study looked at how many people with cystic fibrosis (CF) have antibodies against the COVID-19 virus. Researchers followed 152 adults and children with CF for two years, testing their blood for antibodies and checking their health. The goal was to learn if CF patients are less likely to get COVID-19 and how their bodies respond to infection or vaccination.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CF Centre Innsbruck, Medical University of Innsbruck, Univ. Clinic for Paediatics III

    Innsbruck, Tyrol, 6020, Austria

Conditions

Explore the condition pages connected to this study.